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ABSTRACT
Introduction: Although control strategies for antimicrobial resistance (AMR) have been described
in high-income settings, interventions to curb the emergence and spread of AMR in conflictafflicted low- and middle-income countries (LMICs) have not been systematically explored.
Objective: The objective of this review was to identify and assess the effectiveness of various
control strategies in curbing the emergence and spread of AMR in conflict-afflicted LMICs.
Methods: A systematic scoping review of the literature was conducted using Embase, PubMed, and
Scopus to identify primary literature reporting on AMR in Pakistan, Lebanon, Jordan, or Turkey
published in the last decade (Jan. 2010 – Jan. 2020). Papers were eligible for inclusion if they
discussed conflict or the effects thereof, AMR, and control strategies for AMR. Summary and
reporting of the findings were informed by guidelines presented by Tricco et al. 2018 and the JBI
Reviewer’s Manual for scoping reviews. Semi-structured interviews with experts were conducted to
substantiate review findings. All interviews were audio-recorded and transcribed in full using the
website OTranscribe and the software Descript V.3.3.2.
Results: Sixteen articles were deemed eligible for inclusion. Control strategies discussed in these
articles fell into five categories: infection prevention and control (n=4); antibiotic stewardship
programs (n=3); diagnostics and surveillance (n=7); education (n=2); and other (n=2).
Conclusion: The challenges associated with controlling the emergence and spread of AMR are
exacerbated by violent conflict and displacement. Conflict-afflicted LMICs not only face resource
limitations, but must also find ways to care for and treat injured individuals carrying increasinglyresistant pathogens. The literature and expert opinions suggest that improved lab diagnostics,
implementation of surveillance programs, and infection prevention and control should be prioritized
as AMR control strategies in conflict-afflicted LMICs. However, there is limited research on the
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effectiveness of these interventions in such settings. Future research is needed before adequate
interventions can be designed and implemented.
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INTRODUCTION
Background & Rationale
Rates of antimicrobial resistance (AMR) are on the rise globally.1 Resistance itself emerges when a
subset of pathogens survives within an individual following treatment with an antimicrobial. These
surviving pathogens are oftentimes fitter strains of the microbe which have developed mechanisms
to evade both drug treatment and the immune system. The use of antimicrobials, such as antibiotics,
kill off commensal and pathogenic bacteria in a host. In the absence of competition, resistantmicrobes multiply. Resistance is subsequently spread to other individuals and, in some cases,
resistance may be passed directly from one microbe to another.2 While complications associated
with the treatment of resistant infection and disease endanger the wellbeing of individuals around
the world – claiming nearly 700,000 lives yearly – the burden of AMR is disproportionality felt by
low- and middle-income countries (LMICs).i,4 This imbalance is due to challenges such as weak
governance, economic factors, and technological limitations which oftentimes make it difficult for
LMICs to appropriately manage the emergence and spread of AMR within their borders.4
As the body of literature on AMR in LMICs continues to grow, the difficulties that these
countries face in curbing the emergence and spread of AMR become increasingly apparent.
Solutions such as increased screening for infectious disease,5,6 infection prevention and control,5–7
and improved policy implementation8 have all been suggested. However, the implementation of
such interventions is difficult given resources limitations in many LMICs. The barriers to AMR
control are even greater in LMICs affected by conflict,ii as can be seen in several countries in the
Middle East and North Africa (MENA) region. In Syria, for example, existing drivers of AMR –

i

A country is designated an LMIC based on gross national income per capita cut-offs defined by the World Health
Organization.3
ii
“Conflict,” as it will be used throughout this paper, is defined by Bowsher et al. 2019 and Pettersson et al. 2015 as
“violent armed struggle between hostile groups, resulting in over 25-battle related deaths per year.”3,9
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including the misuse of antibiotics and a lack of early diagnosis of communicable diseases – were
exacerbated by the onset of the civil war in 2011, in part due to the breakdown of the healthcare
system.5,10 Studies on Iraq, a country plagued with political instability and violence since the United
States invaded in 2003, speculate that lack of adequate infection prevention programs in healthcare
clinics, along with poor management of antibiotics, have led to the emergence and nosocomial
transmission of multi-drug resistance (MDR).11,12 Other drivers of AMR worsened by conflict
include delayed access to care, crowded and unsanitary healthcare facilities, shortages in vaccine
supply, and disruption of vaccination schedules.10,13
What’s more, refugees and civilians displaced from conflict-afflictediii regions may
themselves serve as carriers of MDR pathogens, exposing populations in neighboring countries to
increasingly difficult-to-treat diseases.10,14,15 Factors such as poor hygiene, lack of adequate housing,
and inaccess to healthcare services along migration routes all perpetuate this spread of
AMR.6,16,17AMR therefore poses threat not only to citizens of countries affected by active conflict,
but also to surrounding LMICs that serve as host and caretaker of the massive number of displaced
individuals.
According to a 2018 report released by the United Nations Refugee Agency (UNHCR), the
LMICs with the highest number of refugees and displaced peoples relative to their national
population include Lebanon (1 in 6 individuals currently living in Lebanon is a refugee), Jordan (1 in
14), and Turkey (1 in 22).18 This same report lists Pakistan as the country hosting the second largest
total number of refugees, with Turkey hosting the most out of any country in the world.18 The
political, social, and ecological realties in each of these four countries vary vastly. However, they are
alike in that recent studies indicate that the emergence and spread of AMR in these countries is

iii

“Conflict-afflicted,” as it will be used throughout this paper, may refer to a region actively experiencing violent armed
struggle or otherwise experiencing the social and political after-effects of conflict.3 These social and political effects may
include internal displacement or a high volume of refugees entering the country.3
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partially attributable to the flow of migrants, refugees, and injured civilians through their borders. In
Turkey, which contained nearly 2.7 million Syrian refugees in 2016, increased rates of MDR bacterial
infections in war-wounded patients – along with the re-emergence of measles, poliomyelitis,
leishmaniasis, and MDR-tuberculosis (TB) – have provoked concerns over biosecurity within the
country.10 In Jordan, a systematic review found that measles, MDR-TB, and cutaneous leishmaniasis
are also re-emerging there due to the rapid influx of Syrian refugees.19 In Lebanon, a review of data
from 13 hospitals across the country found that there was an observed decrease of 5-10% in the
susceptibility of bacteria to major classes of antibiotics in 2015-2016 compared to 2011-2013.20 In
Pakistan, there is a growing epidemic of cutaneous leishmaniasis in towns neighboring Afghanistan
and in cities with a high number of refugees; increased variability in the clinical presentation of this
disease had complicated treatment and diagnosis.21
The emergence and re-emergence of resistant infectious diseases in these countries
demonstrates the need for increased research on how to control AMR in conflict-afflicted settings.
To the author’s knowledge, this paper will be the first time that the literature has been systematically
searched in order to compile research on control strategies and recommendations put forth by
individuals working in places most affected by the conflict and displacement in the MENA region.
The objective of this review is to compile evidence-based control strategies for AMR in conflictafflicted LMICs and to identify existing research gaps. The goals of this thesis are threefold: (1)
present what is currently being done to address AMR in conflict-afflicted LMICs; (2) compile
recommendations for control put forth by scholars, scientists, and others in the MENA region; (3)
conduct interviews with experts in order to substantiate findings and expand recommendations for
AMR control in resource-variable settings. The qualitative component of this thesis was deemed
exempt by the Institutional Review Board at Yale University.
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It is the author’s hope that this project will help stakeholders to identify gaps in the literature
and inform future research projects on the complex interactions between conflict, displacement, and
AMR. Persistent instability in the MENA region threatens the health and well-being of millions of
people. It is urgent that the global health community more seriously consider conflict as a public
health threat and work toward effective and feasible interventions in the regions most affected.

METHODS
Search Strategy
A systematic scoping review of the literature was conducted using the Joanna Briggs Institute (JBI)
Reviewer’s Manual guidelines on scoping review methodology and summary of evidence.22 The
search was conducted using Embase, PubMed, and Scopus to identify peer-reviewed primary
literature reporting on AMR in Pakistan, Lebanon, Jordan, or Turkey published in the last decade
(Jan. 2010 – Jan. 2020). The structure of the search and summary of the findings was informed by
guidelines presented by Tricco et al. 2018 and the JBI Reviewer’s Manual for scoping reviews.22,23
The author used a Boolean search strategy to combine search terms related to three topic
areas: (1) antimicrobial resistance AND (2) conflict or displacement AND (3) study based in one of
the four specified countries of interest. An initial search was conducted in PubMed. The author
reviewed topical articles, reports, and editorial pieces in order to generate a comprehensive list of
relevant keywords. All identified keywords were carefully tracked in a Microsoft Excel V. 16.31
spreadsheet. A Medical Subject Headings (MeSH) search was conducted using an initial list of
keywords and a review of MeSH tree structures helped to identify additional terms related to the
topics of interest. A complete search of all relevant keywords and MeSH terms was then conducted
in PubMed and 220 records were returned (Table 1).
The platform OVID was used to search articles in Embase. The list of terms identified in the
PubMed search was expanded to include search terms specific to Embase. The author used the
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“Tree Search Tool,” which compiles a list of related searches based on one keyword, to identify
Embase-specific terminology relevant to each of the three topic areas of interest. A comprehensive
search of all identified terms was conducted and 158 records were identified (Table 1). Finally, a
search was conducted in Scopus using the previously identified terms related to the three topic areas
of interest. This search returned 221 records (Table 1).
Table 1 in the Appendix includes a full list of the search terms used for each database. In
total, searches across the three databases returned 599 records.
As per JBI guidance, the author also conducted a number of interviews in order to
substantiate the findings of this scoping review.22 The goal of these interviews was to gain expert
opinion on evidence-based control strategies for AMR in LMICs. Furthermore, these interviews
provided the opportunity to much more explicitly explore the role of violent conflict in the
emergence and spread of AMR, as each interlocutor had some amount of expertise working in
regions or with patients affected by warfare. All interviews were audio-recorded and transcribed in
full by the author using the website OTranscribe and the software Descript V.3.3.2. Major themes
that emerged from these interviews are explored in the Discussion section of this paper.

Inclusion Criteria
All records identified in the search stage were imported to EndNote X9, a citation management
software. One hundred fifty-two duplicate records were eliminated and 447 records were identified
for title and abstract screening. Three hundred ninety-nine articles were subsequently excluded for
the following reasons: published before January 2010 (n=156); not topically relevant (i.e., no explicit
discussion of the three topic areas of interest) (n=237); full-text article was not in English (n=6).
Forty-eight records were thus identified for full-text screening.
To be eligible for inclusion in the review, studies had to be primary research on a topic
related to both antimicrobial resistance and conflict, and be based in Turkey, Pakistan, Jordan, or
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Lebanon. Study types could include retrospective or prospective cohort studies, randomized control
trials, database analyses, or qualitative research studies. Systematic reviews, opinion pieces, editorials,
letters, conference abstracts, and pilot studies were excluded (n=23). To be eligible for inclusion,
articles also had to discuss interventions or strategy recommendations for AMR control. Articles did
not have to discuss the effectiveness of recommended control strategies to be included in this
review. While some studies did provide supporting evidence for the effectiveness of their suggested
control strategies, most mentioned control in their discussion section. Nine articles were excluded
because they did not discuss control.

RESULTS
After screening, 16 articles met the eligibility criteria and
were included in this scoping review (Fig. 1). Six studies
were based in Jordan,12,24–28 two in Pakistan,29,30 six in
Lebanon,31–36 and two in Turkey.37,38 Study populations
included Iraqi, Yemeni, and Syrian
civilians/pateints,12,24,26,37,38 Palestinian refugees,27 Syrian
refugees,31–33,36 Afghani refugees,29 Lebanese patients
and/or individuals residing in Lebanon,32–35physicians in
Jordan,25,28 Turkish patients,38 and others30 (Table 2).

Figure 1

These descriptions of study populations mimic the language used by study authors to describe them,
as not all study authors provided sufficient information on the migration status of their study
population. Ten studies were conducted in a hospital or healthcare clinic,12,24–28,31,32,37,38 two studies
were community based,29,30 and four studies were laboratory based.33–36 Further details on each study
can be found in Table 2 in the Appendix.
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All 16 studies included in this scoping review contained interventions or strategy
recommendations for the control of AMR in conflict-afflicted LMICs. Control strategies fell into
five categories: infection prevention and control (IPC);26,31,32,37 antibiotic stewardship programs
(ASP);12,24,26 diagnostics and surveillance (DS);12,30,33–36,38 education (E);25,27 and other (O).28,29
A complete list of strategy recommendations can be found in Table 3 in the Appendix. Each
strategy type will be explored in further detail below.

Infection Prevention and Control (IPC)
There is some literature to support the effectiveness of infection prevention and control (IPC) to
reduce the emergence and transmission of MDR pathogens in high-income settings.39,40 IPC
interventions include: patient screening, patient isolation, disease surveillance, improved
environmental hygiene, education and training of healthcare personnel, and “judicious use of
antimicrobial agents.”39,40 The goals of IPC are to either prevent infection altogether – thus
preventing the emergence of resistant pathogens – or to control infections such that patients
carrying resistant pathogens are unable to spread them, particularly nosocomially. Four studies
included in this review suggest IPC as a control strategy for AMR in LMICs.
In Lebanon, Rafei and Dabbousi et al., 2013 tested patient samples obtained from warwounded Syrian refugees treated for carbapenem-resistant Acinetobacter baumannii in 2012 at the
Tripoli Government Hospital.31 A. baumannii is an opportunistic nosocomial pathogen that is
associated with high morbidity and mortality and also has an ability to rapidly acquire resistance.32,41
It is a common cause of infection in war and combat wounds.41 The researchers tested four isolates
from patients and found that each contained the resistance-causing gene blaNDM – “the first detection
of carbapenem-resistant A. baumannii carrying the blaNDM gene in Lebanon.”31 They were unable to
identify the source of A. baumannii infection, but concluded that Syria likely serves as a reservoir for
NDM-producing bacteria.31 Based on these study findings, the authors recommend that Lebanese
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hospitals treating Syrian refugees implement infection control measures to prevent the spread of
MDR A. baumannii in healthcare institutions.31
A subsequent study by Rafei (Rafei and Pailhories et al. 2015) tested 116 samples obtained
from Syrian and Lebanese patients (78% male, mean age 40) treated at different hospitals in Tripoli,
Lebanon between 2011 and 2013 for antibiotic susceptibility.32 They found that 60% of the isolates
showed phenotypes consistent with carbapenem resistance: five isolates (four from Syrian patients
and one from a Lebanese patient) exhibited the blaNDM gene.32 The authors speculate that Syrian
refugees likely acquired the infection during a hospital stay in Syria and carried the resistantpathogen to Lebanon, but data to support this speculation was limited.32 In Europe, A. baumannii
susceptibility to antibiotics has decreased from 52.9% in 2009 to 37.7% in 2011; the study authors
share concerns that the emergence of NDM in Lebanon may result in comparable reductions in
antibiotic susceptibility of this nosocomial pathogen.32 Based both on their findings and the fact that
Tripoli is proximate to the Syrian border, the study authors conclude that effective measures to
control the spread of infection in Lebanon are necessary.32 However, the authors do not offer
examples of any specific measures.
In Turkey, Yuce et al. 2017 retrospectively analyzed data collected from Syrian patients
treated for conflict-associated burns at the Dr. Lutfi Kirdar Kartal Educating and Training Hospital
Burn Centre of Istanbul between 2011 and 2015.37 The purpose of this study was to describe the
type of burn wounds that Syrian patients presented with and to provide details on woundmanagement at the burn center.37 According to the authors, analysis of tissue cultures from these
burn victims revealed resistant microorganisms “specific to the battlefield.”37 The authors also
reported nosocomial spread of these resistant-microorganisms in their treatment center, despite
attempts to isolate Syrian patients presenting with war wounds.37 The authors conclude that rapid
transfer of patients with war-associated burns to treatment centers equipped to treat such wounds is
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crucial for infection prevention.37 Early debridement and sterilization of such wounds further helps
to improve treatment outcomes.37
Alga and Herzog et al. 2018a conducted a qualitative study with physicians employed in a
hospital supported by Médecins Sans Frontières (MSF) in Jordan. The goal of their study was to
understand how physicians working in an LMIC and treating war-wounded patients think about
AMR and healthcare-associated infections (HAI).25 The authors interviewed 10 physicians (55%
male, mean age 37).25 All interviews were transcribed and content analyzed by the study authors.25
When asked about HAI, physicians recognized a lack of staff adherence to hospital protocols as
attributable to the spread of pathogens.25 However, physicians qualified this lack of adherence with a
limitation of resources as a reason that adherence proved difficult.25 Specifically, physicians cited lack
of bed sheets, shortage of appropriate antibiotics, and space limitations as barriers to infection
prevention.25 On the topic of AMR, participants cited main challenges as being costs associated with
antibiotic treatment and space limitations that precluded antibiotic-resistant patients from being
isolated.25 Physicians also pointed out that antibiotics are commonly available over the counter in
Syria and Lebanon, and therefore patient behavior might also be a contributing factor to AMR
emergence.25 The findings from this study present just some of the challenges to IPC in a resourcelimited setting. The authors believe that increased access to resources (e.g., bed sheets, antibiotics,
etc.) is necessary for control AMR in this setting.25

Antibiotic Stewardship Program (ASP)
Inappropriate antibiotic use and prescribing are not only burdensome and costly to healthcare
systems, but also drive the emergence of multi-drug resistant pathogens and organisms.24,42,43 An
ASP is a program in which antibiotic use within a healthcare institution is monitored or directed by a
trained group of individuals such that antibiotic use is standardized and evidence based.42
Interventions used in ASPs include avoidance of use of broad-spectrum antimicrobials, optimization
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of dose and route of administration per patient, and customization of duration of therapy such that
antibiotic use is curative, rather than palliative, in nature.42 In high-income settings, ASPs have been
shown to reduce the emergence of AMR, but evidence for their effectiveness in LMICs is
limited.24,43 Three studies included in this review suggest implementation of ASPs as control
strategies for AMR in LMICs.
Bhalla et al. 2016 assessed the effectiveness of an ASP implemented in the MSF
Reconstructive Surgery Project in Amman, Jordan.24 The Reconstructive Surgery Project treats about
50 patients per month, predominantly from Iraq, Syria, and Yemen.24 At this center, patients with
suspected osteomyelitis (a type of bone infection) undergo exploratory surgery, during which tissue
samples are collected and tested for resistance.24 The authors found that of those carrying resistant
pathogens, the most common were cephalosporin-resistant Enterobacteriaceae or methicillin-resistant
Staphylococcus aureus.24 To help control spread of these resistant pathogens, an ASP team was
assembled in October, 2013 and composed of a physician and a pharmacist.24 They were tasked with
using patient-level microbiology results to inform decisions of antibiotic selection, dose of
medication, duration of treatment, and route of administration.24 Within the first year of the
program, the ASP team recommended a change in the antibiotic regimen of 45% of patients (106 of
233 patients); the rate of acceptance of these recommendations by the medical team was 88% (94 of
106 patients).24 The authors found that though patient load at this MSF center remained relativity
the same, the ASP reduced antibiotic costs from $252,077 to <$159,948 in just one year.24 They
credit the reduction in improper use of imipenem, shifts in prescribing practices (e.g., waiting to
initiate treatment until after culture reporting), and increased responsibility for antibiotic
management by surgeons as program changes that helped to reduce costs.24
Fily et al. 2019 retrospectively analyzed laboratory data from the same MSF Reconstructive
Surgery Project assessed by Bhalla et al. They analyzed 727 bone samples collected between October
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2006 and December 2016 from war-wounded Iraqi, Yemeni, and Syrian patients.12 Their objective
was to describe first-line antibiotic resistance (FLAR) among civilians at risk for post-traumatic
osteomyelitis (PTO) and to identify patient risk factors for PTO.12 Commensal pathogens,
environmental contamination, and nosocomial spread of MDR pathogens are all causes of PTO in
LMICs and particularly in conflicted-afflicted LMICs.12 PTO treatment includes prolonged antibiotic
use, aggressive debridement and, in some cases, reconstructive surgery may be required. 12 Thus, the
emergence or transmission of MDR pathogens poses significant threat to effective PTO treatment
and may impact patient outcomes. The authors found that of the 727 patient isolates analyzed,
roughly 50% were FLAR; of those resistant pathogen strains identified, 60.5% were S. aures.12 These
pathogens were found to be resistant to fluroquinolones, rifampin, and oxacillan.12 A multivariable
analysis conducted by the authors revealed that FLAR infections were associated with lower
extremity infection, time since injury <12 months (compared with >30 months), and with >3
previous surgeries.12 Based on their findings, Fily et al. suggest the implementation of a strong ASP
and use of second-line antibiotics when treating PTO in war-wounded patients.12 However, the
authors make no references to the ASP implemented at this study site in 2016, as described by
Bhalla et al., which is a limitation of their discussion.
Alga and Wong et al. 2016 conducted an open cohort study with longitudinal data collected
from war-wounded Syrian civilians seeking care at an MSF-supported hospital in Jordan between
2014 and 2016.26 They collected data on 457 patients (86% male, mean age 27).26 The authors used
logistic regression models to understand differences in outcome and resource use based on infection
status.26 Infection status was determined by culture results and clinical presentation of the wound.26
Eleven percent of their cohort had an infected war wound and of these, 73% of the infections were
MDR.26 They identified Klebsiella pneumoniae, Enterobacteria, and Escherichia coli as the pathogen strains
resistant to the most antimicrobials.26 According to their statistical analysis, those with infected war
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wounds required an average of 12 surgeries when compared to non-infected patients, who required
an average of five surgeries (p<0.00001).26 Further, infected patients were hospitalized for about 77
days, as compared to 35 days for non-infected patients (p=0.000001).26 Patients with infected
injuries were also subject to a higher number of amputations.26 The authors conclude that warwound infections are associated with high resource consumption, worsened clinical outcomes for
patients, and a higher occurrence of MDR pathogens.26 Based on these findings, they call for the
development of “antibiotic protocols and adaptations of surgical management” to better the quality
of care received by patients suffering from war-related injuries.26

Diagnostics and Surveillance (DS)
The capacity for microbiological surveillance of disease emergence and spread is oftentimes limited
in LMICs due to resource constraints. Challenges include financial barriers, absence of culture
samples, and infrastructural constraints (e.g., water supply, electricity supply, waste management,
etc.).43 Given these challenges, resistance is only sporadically tested for in many low-resource health
clinics and hospitals.13 In extremely resource-limited regions, such as Gaza, AMR is only reported
anecdotally with no capacity to gather data to support the extent of its prevalence.44 In order for
ASPs to be effective, prescribers require specific and accurate information on the type of resistant
pathogens that a patient carries in order to inform clinical decisions.43 Furthermore, ineffective or
insufficient disease surveillance programs may be detrimental to infectious disease prevention and
control efforts. One example is the spread of TB in LMICs. In 2016, nearly 40% of individuals
worldwide – that is, nearly 4.1 million individuals – either failed to be diagnosed with TB or failed to
have their disease status reported to a national TB surveillance program.45,46 Such gaps in surveillance
efforts are significant given that TB ranked as the ninth leading cause of deaths globally that year
and also that TB-causing pathogens rapidly acquire resistance to treatment.45,46 Specific and sensitive
diagnostics and robust surveillance systems are therefore necessary for the control of infectious
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diseases. By extension, these measures may also be necessary for adequate AMR control. Seven
studies included in this review, a number of which focused on TB, discuss the importance of
diagnostic tools and surveillance in AMR management.
In Lebanon, Hamze et al. 2015 evaluated the efficacy of pyrosequencing technology to
detect mycobacterium tuberculous resistant to rifampicin (RIF) and isoniazid (INH) in isolates
collected from Syrian refugees and Lebanese patients.33 RIF and INH were of interest to the
researchers as MDR-TB is defined by a resistance to both these antibiotics.33,34 Before the Syrian
civil war started, Lebanon had seen a decrease in incident TB cases.33 However, as of 2014, nearly
14% of all TB cases in Lebanon were among Syrian nationals, with some number of these cases
being MDR-TB.33 Traditional culture-based tests for resistant TB may take up to 4 weeks to yield
results; the researchers wanted to test pyrosequencing assays as an alternative diagnostic tool.33 They
found that pyrosequencing, which sequences short DNA segments, applied to 66 clinical isolates
was able to detect INH-resistant strains with 72.6% sensitivity.33 Thus, the authors recommend the
use of pyrosequencing as a rapid and sensitive diagnostic tool that should be used to inform clinical
decisions regarding TB treatment.33
Araj et al. 2016 conducted a retrospective study to generate data on TB and MDR-TB in
Lebanon, given the lack of robust surveillance programs in the country.34 Their data sources
included the National Tuberculosis Program (NTP) and the Clinical Microbiology Lab (CML) at the
American University of Beirut.34 The goal of this study was to assess trends in TB incidence and
prevalence in Lebanon from 1999 to 2013.34 The researchers found that in 2001, the incidence of TB
was 13/100,000 population; by 2006, the incidence had dropped to 9/100,000 population.34
However, by 2013 – two years after the onset of the civil war in Syria – the incidence of TB reached
20/100,000.34 They conclude that this rise in TB incidence is attributable to TB cases in nonLebanese nationals and Syrian refugees.34 Among the identified MDR-TB cases, resistance was
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highest to INH followed by resistance to RIF.34 The author’s cite limitations of their study as being
incomplete and non-comprehensive data due to restricted reporting to TB surveillance programs.34
They conclude that “rapid and reliable” diagnostics are necessary such that TB may be diagnosed
early and treated.34 In their own labs at the American University of Beirut Medical Center, the
authors employ automated instruments and the TB Gene Xpert (Cephid) as diagnostic tools.34
In another study based in Lebanon, El Achkar et al. 2019 tested 720 samples collected by the
Lebanese National TB program from patients suspected of having TB between June 1, 2016
through May 31, 2017.35 Samples were collected from individuals from Syria, Lebanon, Ethiopia,
Palestine, Bangladesh, and elsewhere.35 Two-hundred eighty four cases of TB were confirmed based
on culture results and Xpert MTB/RIF (Cepheid) molecular testing.35 Xpert testing was also used to
determine resistance. The authors found that of a subset of 250 patients, 2.8% were resistant to
RIF.35 The authors used multivariable regression to test if prior TB infection was associated with
RIF resistance and found that resistance was 22.8% among patients previously treated with the
drug.35 They conclude that while resistance to RIF in their study population was fairly low, the three
MDR-TB and three XDR-TB strains discovered in their study had “strong epidemic potential and
complex resistance patterns.”35 The authors thus recommend that TB-positive patients in Lebanon
be tested for drug resistance in order to better inform treatment decisions and to ensure that
appropriate antibiotics are used.35
In Pakistan, Ghafoor et al. 2012 conducted a cross-sectional study on TB management
involving 139 patients (51% male, mean age 31) who resided in the Khyber Pakhtunkhwa (KP)
Province.30 The KP Province was selected for this study in part due to the large population of
Afghan refugees who live there, and also because conflict and displacement in the KP Province have
disrupted past TB control efforts.30 The goal of this study was to describe the prevalence of MDRTB in this region by recruiting patients and sorting them into two groups: residents with TB who
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never received treatment (CAT I) and residents with TB who received treatment but failed to
respond or relapsed (CAT II).30 The authors found that nearly 58% of patients in their study had
MDR-TB: of those individuals, MDR-TB was more prevalent in the CAT II patients who failed
treatment (76% prevalence) than in CAT I patients (62% prevalence).30 The authors conclude that
patients with a history of TB treatment failure are uniquely at risk for MDR-TB.30 They further state
that improved disease and resistance surveillance are important aspects of TB management in this
region.30
In Turkey, Dogru et al. 2017 conducted a retrospective comparative analysis of incident TB
cases and treatment success between Turkish and Syrian patients registered at the TB Outpatient
Clinic in the Hatay Province between 2010 and 2013.38 This province was selected for the study as it
is home to a high number of displaced Syrian refugees.38 The goal of the study was to record
incident TB cases and compare treatment success between Turkish and Syrian patient populations.38
The authors enrolled 178 Turkish patients (67% male, mean age 45) and 33 Syrian patients (61%
male, mean age 32) to the study (n=211).38 It was found that treatment success rates amongst Syrian
patients were lower than Turkish patients (64% vs. 89%, p<0.001) and that Syrian patients failed to
complete treatment at a higher rate than Turkish patients (30% vs. 4%, p<0.001).38 Resistant TB was
documented in 3 Turkish patients and 1 Syrian patient in this study population.38 To account for the
lower treatment success rate in Syrian refugee patients, the authors recommend the implementation
of a national TB control program that emphasizes the surveillance and treatment of refugees with
TB.38
The authors of two studies discussed improved diagnostics and surveillance for diseases
other than TB. The first study was by Salloum et al. 2018. As a part of their case report, these
researchers conducted a comparative genome analysis of a MDR Streptococcus pneumoniae responsible
for the death of a 10-month old Syrian infant in Lebanon.36 They compared this isolate with 24

21
other S. pneumoniae genome sequences which they obtained from a publicly available database.36 The
researchers investigated virulence factors, resistance mechanisms, and other characteristics of the
strains in their comparison.36 They found that the isolate from the Syrian infant exhibited resistance
to a number of drugs and also that regions of the genome were highly diverse, which the authors
state “could account for the pronounced invasiveness of this isolate.”36 Given the isolates potential
for rapid spread, the authors suggest the implementation of surveillance for S. pneumoniae in
Lebanon, and recommend the use of whole genome sequencing to support these efforts.36
The second study was by Fily et al. 2019, who analyzed bone biopsy samples collected from
Iraqi, Syrian, and Yemeni patients with infected war wounds presenting for care at an MSFsupported program in Jordan (full study described under ASP). These authors cite missing data
(particularly on Iraqi patients), sample contamination, and the “laboratory origin of their database”
as limitations of their analyses.12 To circumvent sample contamination concerns, the authors only
tested bone biopsy cultures for antibiotic susceptibility, as tests using deep tissue samples lack
sensitivity and specificity.12 Based on their experiences, the authors state that improved laboratory
conditions and enhanced data collection and management are necessary to appropriately manage S.
aureus and Enterobacteriaceae resistance in patients with PTO.12

Education (E)
The use of any antimicrobial applies selective pressure on pathogenic organisms, facilitating the
emergence of drug-resistant pathogen strains.47 The overuse and misuse of antibiotics exacerbates
this process. For example, despite antibiotics being ineffective for the treatment of viral infections,
they are oftentimes prescribed in high-income settings to treat coughs, colds, and viral sore throats.47
In countries such as Syria and Lebanon, antibiotics are readily available for purchase over the
counter and without a prescription, which make the problem of overuse particularly challenging to
address.48 Therefore, increased education on appropriate antibiotic usage on the population and
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clinical level is often cited as necessary steps towards controlling these key drivers of AMR. Two
studies included in this review address education as an AMR control strategy.
In Jordan, Al Baz et al. 2017 used a cross-sectional, interviewer administered survey to study
the knowledge, attitudes, and behaviors of Palestinian refugees (18% male, median age 32) regarding
their antibiotic use.27 The 250 refugees who participated in this study were recruited at one of four
United Nations Relief and Works Agency (UNRWA) health centers.27 Antibiotic use amongst this
population was high, with 47% reporting one or more uses of antibiotics in the three months prior
to survey administration.27 Self-medication – defined by study authors as “using leftover antibiotics,
sharing antibiotics at home and purchasing antibiotics over the counter without prescription” – was
also high.27 Of the respondents, 63% reported that they shared their antibiotics with others, 38%
had used leftover antibiotics, and 60% purchased their drugs over the counter.27 The authors used
logistic regression to model inappropriate antibiotic use. After adjusting for potential confounders,
they found that patients who perceived there to be long wait times at health clinic had two times the
risk of self-medication compared to those who perceived short wait times.27 These individual also
had 1.7 times the odds of purchasing drugs over the counter.27 Income, age, employment, and
education level were not found to significantly affect self-medication in this study population.27
Given these findings, the authors recommend that interventions work on the community-level to
promote education on appropriate antibiotic use.27 Also, given that 90% of respondents indicated
that they trust their healthcare providers, the authors encourage increased counseling from the
medical staff on appropriate antibiotic use.27
Another study based in Jordan was by Alga and Herzog et al. 2018a, who conducted a
qualitative study on physicians employed in an MSF-supported hospital to capture their perspective
on AMR and hospital-based infections (full study described under IPC). Physicians in this study
regarded patient behavior as a contributing factor to AMR: notably, they cited concerns over

23
patients’ ability to purchase drugs over the counter, as well as premature discontinuation of
antibiotic use by patients.25 No physician in this study identified a direct link between the emergence
of a HAI and the spread of AMR, despite these two factors being interrelated.25 Further, physicians
had variable opinions on behaviors that may result in HAIs – e.g., hand hygiene was mentioned by
some physicians as a behavioral factor that does contribute to the emergence of HAIs, while it was
mentioned by others as a factor that does not contribute to HAIs.25 Based on these findings, the
authors recommend increased training of healthcare professionals on the importance of hand
hygiene compliance.25 They also recommend increased resource allocation as an intervention to
improve adherence to hygiene protocols.25

Other (O)
Combination antibiotic therapies are believed to be an effective treatment approach for patients
carrying resistant pathogens.49 Many infectious agents mutate and acquire resistance faster than new
medications can be developed to treat patients; careful combination of existing therapies is a means
of killing these resistant agents and allows for increased therapy options in lieu of novel scientific
advances.49 Combination therapies are currently in use to treat resistant TB, human
immunodeficiency virus (HIV), and malaria.29,49 One study included in this review considered
combination therapy use as an intervention on AMR.
In Pakistan, Kolaczinski et al. 2012 recruited 308 Afghan refugees (58% male) with
falciparum malaria from five villages near the Peshawar Provence for a randomized control trial.29
They randomized participants to one of six treatment arms in order to determine which treatment
arm was most effective against malaria.29 The treatment arms were as follows: (1) chloroquine (CQ);
(2) CQ + single dose of gametocytocidal primaquine (PQ); (3) CQ + three doses of artesunate (AS);
(4) sulfadoxine-pyrimethamine (SP); (5) SP + single dose PQ; (6) SP + three doses AS.29 At the time
that the study was initiated, CQ was the first-line treatment used for malaria, despite widespread
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resistance to the drug.29 In their study, the authors found that patients treated with CQ had a
treatment failure rate of 81% at 28 days follow-up.29 However, patients treated with SP + AS had a
failure rate of 2.4% at follow-up.29 Based on these findings, CQ treatment was replaced with SP +
AS combination therapy in the World Health Organization Eastern Mediterranean Region.29 The
authors caution, however, that mono-therapeutic use of SP, which is still common in the region,
may lead to future resistance to SP.29
Protocols and guidelines used to treat civilians with war injuries were first developed by the
International Committee of the Red Cross (ICRC) as early as 1988.50 Today, MSF-supported
hospitals continue to adhere to ICRC guidelines for the treatment of civilians harmed during
conflict.28 As discussed in the IPC section of this paper, appropriate management of war wounds is
necessary to circumvent infection and the subsequent emergence and spread of AMR pathogens.
However, healthcare workers in resource-limited settings are not always able to fully comply.28 One
study included in this review considered the development of new guidelines and protocols for
conflict-afflicted settings as a way to improve adherence and compliance.
Alga and Herzog et al. conducted two separate qualitative studies with physicians employed
by an MSF-supported hospital in Jordan. The first study (Alga and Herzog 2018a) was described in
the IPC and E sections of this review. Their second study (Alga and Herzog 2018b) sought to
capture physician opinion regarding perceived challenges to war wound management in the hospital
setting.28 In total, they conducted 10 semi-structured interviews with physicians (60% male, mean
age 37), transcribed the interviews, and content analyzed them.28 They found that the largest barrier
to appropriate wound management reported in this setting was poor protocol adherence.28 Some
barriers to adherence identified by physicians included: “(i) lack of medication or equipment, (ii) lack
of space, (iii) patient and caregiver behavior.”28 The authors point out that these barriers are not
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insurmountable. To overcome them, they suggest that future studies be conducted in order to
develop new guidelines and protocols for resource-constrained hospitals.28

DISCUSSION
Main Findings
The interventions identified in this scoping review predominantly fall into five categories: infection
prevention and control (discussed in four studies); antibiotic stewardship programs (discussed in
three studies); diagnostics and surveillance (discussed in seven studies); education (discussed in two
studies); and other (discussed in two studies).
While an initial goal of this analysis was to identify “best” control strategies for AMR in
conflict-afflicted LMICs, a majority of the articles deemed eligible for inclusion did not offer a
discussion of the effectiveness of their proposed interventions. Further, the complexity of the issue
at hand makes it apparent that no one intervention is likely to be sufficient in managing the
emergence and spread of AMR. Only three studies included in this review assessed the effectiveness
of their proposed interventions. Bhalla et al. 2016 assessed the implementation of an ASP in a health
clinic in Jordan and found that it did reduce antibiotic costs and improved antibiotic utilization
practices.24 Hamze et al. 2015 explored lab diagnostics and found that use of pyrosequencing
technology improved sensitivity testing for MDR-TB in Jordan and also allowed for more rapid
testing for resistance.33 Kolaczkinski et al. 2012 showed that individuals treated with SP + AS had
lower clinical failure rates during malaria treatment than those treated with CQ, a drug which
malarial pathogens are highly resistant to.29 These studies provide support for ASPs, DS, and
combination therapy, respectively.
Though based on primary research findings and the authors’ expertise, recommendations
offered in the remaining papers were at best speculative given the limited research to support the
effectiveness of the interventions in low-resource settings. Research on the feasibility and utility of
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IPC, education, and implementation of new guidelines is especially needed given that no studies
included in this review spoke to their effectiveness.
To further contextualize the findings of this scoping review, semi-structured qualitative
interviews were conducted with experts to gain their opinions on the identified intervention
categories. Interlocutors included: a physician at the Syrian America Medical Society (SAMS) (P1); an
academic with expertise on AMR in conflict-afflicted countries (P2); a doctor and clinical leader on
AMR at MSF (P3); and a microbiologist at MSF (P4). Two main takeaways emerged from these
interviews: (1) heavy metals and environmental contaminants due to warfare are key drivers of AMR
and (2) interventions must be tailored to the resource availability of a given region.

Role of Heavy Metals
A. baumannii is regarded as one of the most burdensome pathogens to emerge and cause infection in
times of conflict.iv This bacterial pathogen readily acquires multi-drug resistance and spreads quickly
both nosocomially and within the community.51 A. baumannii has a number of resistance
mechanisms, but a primary mechanism is biofilm formation, which protects the pathogen from
drugs and host immune response.51 A. baumannii was documented as being the most prevalent
infection-causing pathogen in war-wounded individuals during wars in Iraq, Lebanon, and
Afghanistan.51–53 In fact, this pathogen became so well known for its role in causing wound
infections in U.S. soldiers returning from Iraq that it was nicknamed “Iraqibacter.”53
Heavy metals play a role in selecting for resistance amongst pathogen species and are
increasingly being identified as key drivers of resistant A. baumannii infection in war-wounded
individuals.53 Heavy metals, defined as a “group of non-biodegradable metals and semi-metals
(Metalloids),” are readily available in the environment and are often used in the development of

iv

This pathogen is also described by Rafei and Dabbousi et al. 2013 and Rafei and Pailhories et al. 2015 in the IPC
section of this paper.
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antimicrobials and chemotherapies.53 Heavy metals are also used in weapon production, and are
present in large quantities in missiles, bullets, military vehicles, and explosives.53 Specific resistance
mechanisms related to heavy metals are beyond the scope of this paper and are described elsewhere
by Bazzi et al. 2020.53 However, their main importance to this discussion is their role in applying a
selective pressure that allows for the persistence of resistant pathogens.54
Widescale weapon use contaminates the environment with abnormal levels of heavy metals
and, therefore, warfare has direct ecological impacts that drive AMR.55 While supplementary factors
such as inappropriate antibiotic use and inadequate antibiotic stewardship likely play a role in the
emergence and spread of AMR in conflict-afflicted regions, it is critical that the issue of AMR at
large not be reduced to a behavioral one. This point is best explained by P2, an academic with
expertise in the political and environmental ramifications of warfare on AMR. When asked what he
believed the role of antibiotic stewardship to be in the global response to AMR, he said the
following:
“Yes, I think that the risk of… of obscuring the conflict, in terms of what it’s
doing and in terms of the environmental damage and the physical injuries and
the destruction of these healthcare, you end up really reducing this problem to
really, a behavioral problem. And you are expecting people in a war zone or in
a conflict setting, that they will have to kind of abide by WHO guidelines while
they are being bombed left and right by whoever… I mean, it feels like
sometimes people are living in La La Land when they talk like that, you know?
But all we need to improve stewardship and improve antibiotic prescription. I
mean, but when you go to Idlib or Mosul and you see the situation… this is
the last of your concerns. Having said that, that’s not necessarily a bad idea, to
begin to raise awareness and explore these problems and the prevention. But
again, the issue – the bigger issue – is the whole war and the war ecology…”
This excerpt makes clear the additional considerations that must be kept in mind when an LMIC is
confronted not only with a limitation of resources, but also active violent conflict. While there are
behavioral components of AMR that health systems might address with interventions identified in
this paper – notably, education and the implementation of ASPs – it is crucial to recognize that
some barriers to effective AMR control are simply beyond the capacity of already struggling health
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systems and people. In idealistic terms, the best control for AMR in conflict-afflicted LMICs would
be an immediate ceasefire of all violent conflict, especially in the MENA region. In the absence of
such ceasefire, however, the global health community must think more strategically about AMR
interventions that are tailored to local capabilities and capacities. MSF has been a leader in such
thinking, and has presented a structure for deciding on effective AMR interventions in conflictedafflicted LMICs. Their intervention recommendations are explored below.

Tailoring Interventions
In 2015, the WHO released a report titled the “Global Action Plan on Antimicrobial Resistance.”
The five objectives identified in this plan include: (1) increased educational awareness of AMR and
its drivers; (2) improved surveillance of and research on AMR; (3) infection prevention and control;
(4) optimization of antibiotic use in humans and animals; and (5) sustained investment in the
development of new drugs, therapies, and diagnostics.56 While this report acknowledges that AMR
prevention and control necessarily looks different in LMICs, the guidance offered to these countries
is minimal and ultimately lacks the specificity required for effective intervention. The authors of the
report recognize this limitation and identify lack of research on treatment and IPC, as well as
minimal data, as barriers to effective AMR control in LMICs.56
In the same year, MSF released their “Roadmap on Antibacterial Resistance.” Given the
presence of MSF predominately in LMICs, this document explicitly addresses control and its
associated challenges in low-resource settings. Many of the objectives identified in the MSF plan are
comparable to those in the WHO plan – e.g., stewardship, surveillance, improved lab diagnostics,
infection prevention, etc.57 However, the plans differ in that MSF writes specifically on antibiotic
resistance (ABR), rather than AMR more generally, and MSF also tailors their recommendations
based on existent lab and diagnostic infrastructure in each of their operational sites.57 In a
subsequent 2019-2020 strategic plan released by MSF, they propose two “packages” for ABR
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control. The first package recommends that all MSF healthcare facilities – regardless of their
capacity to conduct microbiology research – should, at the minimum, implement an ASP and an IPC
plan.58 The second package, called a “full package,” recommends the implementation of an ASP,
IPC, and “access to microbiology.”58 This access would ensure that appropriate diagnostic tools and
lab infrastructure are in place such that identification of infection-causing agents, tailored antibiotic
treatment with specificity to the infectious pathogen, and time-sensitive detection of resistance are
possible.58 Given the importance of microbiology data in ABR control, MSF has helped to support
microbiology labs at 14 of their project sites, including a lab in Jordan.59
However, the establishment of a lab is not always feasible, and it is in the absence of
microbiology that interventions must be creatively modified to fit local capacities and resources.
According to an MSF researcher who works on ABR (P3), education- and behavior-based
interventions become particularly important in regions that lack microbiology access. P3 identifies
the following as supplemental actions that might be taken in regions where full-package ABR
control is not possible:
“The only thing that we do in places that is where there is no access to
antibiotic… we try to improve the clinical scheme of the people doing external
consultation, or we call it OPD, is outpatient departments. This person is key
as well in the most of the places that we work because this person will decide
if one patient will get some antibiotics or not or if the patient needs to be
hospitalized or not. We developed… a tool that is called e-Care and the e-Care
is kind of like an app based with the tablet and the ideas to help the clinician
to take the right decision.”
Here, P3 is describing an iteration of an ASP program which uses the outpatient setting as a
backdrop for intervention. While an app-based system presumes access to technology and Internet
service, this strategy provides an example of how interventions identified in this paper may be
adapted to the context in which they are implemented. Investment in improved lab diagnostics is
sorely needed in LMICs most affected by conflict; however, there are other opportunities to
intervene in the absence of microbiology. When asked if they believed that improved lab diagnostics
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was the predominant intervention needed to curb AMR, a microbiologist who has helped MSF to
open a number of labs around the world (P4) disagreed and said the following:
“No, I would say infection prevention and control as... as it is really like the,
the, the main pillar. It’s like, without that, you can rationalize the use of all the
antibiotics, you can put diagnostic tests everywhere. You are just going to
diagnose what you are creating in your own hospital, which is going to be a
loss of time, loss of money, and loss of life.”
In other words, hospitals and healthcare facilities must take sufficient action to try and prevent the
emergence of resistance-prone infections altogether. Otherwise, the implementation of ASPs and
the use of lab diagnostics may just be reactionary measures that fail to adequately address the roots
of the problem. However, P4 cautions that the implementation of IPC measures is no easy task.
Challenges to IPC range from war-related factors (e.g., heavy metals in the environment) to resource
constraints in the hospital setting. As thus, P4 believes that future research is needed in order to
inform effective IPC program design and to improve adherence to IPC guidelines by medical staff.
In the interim, actions taken by MSF and other organizations with expertise in conflictafflicted LMICs should be studied closely as examples of how interventions on AMR may be
formulated and implemented. As P3 states in their interview, despite there being a number of
different guidelines that have been proposed by public and global health bodies, the most successful
control of AMR will only be possible if healthcare systems themselves are provided with the capacity
to conduct research and understand the epidemiological spread of pathogens and resistance in their
facilities. In the absence of such research and data, AMR interventions will continue to lack the
epidemiologic grounding needed to be effective. Furthermore, as P2 and P4 discuss, interventions
must equally target both the emergence and spread of AMR; while these phenomena are certainly
related to one another, they are also distinct issues that require their own specific interventions.
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LIMITATIONS
There are a number of limitations to this scoping review. Foremost, all searchers were conducted in
English and only papers published in English were eligible for inclusion, despite the focus of this
review on regions where English is not the predominant language. Additionally, this review was
limited to primary research on only four conflicted-afflicted LMICs in the MENA region. It is
possible that other intervention strategies might have been identified if the search were expanded to
include grey literature or other conflict-afflicted countries around the world. A limitation of the
qualitative component of this paper was that only four interviews were able to be completed, despite
the extension of more than ten interview requests. However, the completed interviews did provide
key insights – a greater number and diversity of interviews in future research of this nature would
allow for more rigorous and theory-based thematic analyses of expert opinion.

CONCLUSION
The challenges associated with containing the emergence and spread of AMR are exacerbated by
violence, conflict, and displacement. Conflict-afflicted LMICs not only face resource limitations, but
must also find ways to care for and treat injured individuals who carry increasingly-resistant
pathogens. This scoping review identified five key intervention categories for AMR control in
conflict-afflicted LMICs: (1) infection prevention and control; (2) antibiotic stewardship programs;
(3) diagnostics and surveillance; (4) education; and (5) other. Based on what is currently known in
the literature and expert opinions, a major takeaway from this review is that improved lab
diagnostics, implementation of surveillance programs, and infection prevention and control should
all be prioritized in efforts to control AMR in conflicted-afflicted LMICs. However, there is limited
primary research on the effectiveness of all identified intervention strategies in such settings. In
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particular, a major gap in the literature identified by this review was the absence of primary studies
on the effectiveness of education-based interventions and IPC in conflict-afflicted countries.
As violent conflict persists around the world, it is critical that the threat of antimicrobial
resistance is responded to appropriately and immediately. In order to respond, however, increased
data and primary research on AMR in conflict-afflicted regions is sorely needed. To be effective,
interventions must be uniquely tailored to the political, social, and ecological realities of the
countries that they are implemented in. Furthermore, the problems and challenges identified
throughout this paper go far beyond countries actively experiencing violence or warfare: resistant
pathogens oftentimes become unwanted cargo, carried unknowingly by those fleeing humanitarian
disaster. The global health community should leverage this fact to increase research funding and
attention to the unique dangers of AMR in conflict-afflicted regions – e.g., its exacerbated potential
for spread in these settings. In engaging in such research, however, it is critically important that
displaced individuals and refugees themselves are not pathologized and solely blamed for AMR. As
P2 explained in his interview, the entire war system – including the targeted breakdown of
healthcare infrastructure, sanctions that render it impossible to import needed medications and
medical supplies, impact of weaponry on the environment and water sources, and so on – must all
be considered as drivers of AMR. Ultimately, the struggle to provide care to those most in need will
only increase as antibiotics continue to fail to cure illness and infection. Prompt action by the global
health community is necessary; the findings of this analysis provide preliminary guidance on where
to begin in the fight against AMR in conflict-afflicted LMICs.
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APPENDIX
Table 1. Full Search Strategy per Database
Search
Category
Conflict

Antimicrobial
Resistance

Region

Full Search

PubMed
(1) conflict*[tw] OR warfare[tw] OR
war[tw] OR displace*[tw] OR refugee*[tw]
OR violence[mesh] OR violen*[tw] OR
war-related injuries[mesh] OR warfare and
armed conflicts[mesh] OR refugees[mesh]
OR wound infection[mesh] OR "asylum
seeker"[tw] OR "war wound*"[tw]
(2) Anti-Bacterial Agents / therapeutic
use[mesh] OR Drug Utilization /
standards[mesh] OR antibacterial
agents/therapeutic use[mesh] OR drug
resistance, bacterial[mesh] OR resistan*[tw]
OR AMR[tw] OR ABR[tw] OR Bacterial
Infections/microbiology[mesh] OR
MDR[tw]
(3) Turkey[tw] OR Turkish[tw] OR
Jordan[tw] OR Jordanian*[tw] OR
Lebanon[tw] OR Lebanese[tw] OR
Pakistan*[tw] OR middle east*[tw] OR
Middle East[mh:noexp] OR Turkey[mh]
OR Jordan[mh] OR Pakistan[mh] OR
Lebanon[mh]
1 AND 2 AND 3

Embase

Scopus

(1) (((violen* OR armed conflict OR warrelated injuries OR refugee* or displac*
OR wound infection OR asylum seeker
OR war wound*).mp.) OR (*war/ OR
*refugee/))

(1) TITLE-ABS-KEY (conflict* OR war*
OR displac* OR refugee* OR "armed
conflict*" OR “war-related injuries” OR
violen* OR “asylum seeker” OR “war
wound”)

(2) ((drug resistance/ OR drug resistance,
microbial/ OR drug resistance, bacterial/
OR drug resistance, multiple, bacterial/
OR drug resistance, viral/ OR drug
resistance, multiple, viral/ or drug
resistance, multiple/) OR (AMR OR MDR
OR ABR OR resistan*).mp.)

(2) TITLE-ABS-KEY ("drug resistan*"
OR "AMR" OR "MDR" OR "multidrug
resistan*" OR "acquired resistance" OR
“ABR” OR "bacterial resistance”)

(3) ((Middle East/) OR (Jordan OR
Jordanian OR Lebanon OR Lebanese OR
Turkey OR Turkish OR Pakistan OR
Pakistani OR Middle East).mp.)

(3) TITLE-ABS-KEY (Turkey OR Turkish
OR Jordan OR Jordanian OR Lebanon
OR Lebanese OR Pakistan OR Pakistani
OR “Middle East”)

1 AND 2 AND 3

1 AND 2 AND 3

ii

Table 2. Description of Final Study Set
Authors

Study
Site

Study Population

Study Details

Sample
Size

Jordan
Jordan

Iraqi, Syrian, and Yemini
patients with chronic
multidrug-resistant
infections

Al Baz et al.,
2017

Jordan

Palestinian refugees (18%
male, median age 32)

Alga & Herzog
et al., 2018a

Jordan

Alga & Herzog
et al., 2018b

Jordan

Alga & Wong
et al., 2018

Jordan

Fily et al., 2019

Jordan

Ghafoor et al.,
2012

Pakistan

Kolaczinski et
al., 2012

Pakistan

Bhalla et al.,
2016

Patients treated at the MSF Reconstructive Surgery Project in Amman; ASP
implemented by MSF at this site; program reduced antibiotic cost by ~$92,129
over one-year period

Patients treated at one of four UNRWA health centers; interviewed regarding
knowledge and use of antibiotics; 63% shared antibiotics, 38% used leftover
antibiotics, 60% purchased drugs over-the-counter
Physicians employed by an MSF-supported hospital; interviewed regarding
Physicians (55% male, mean
views and attitudes on AMR and HAIs; most providers did not acknowledge a
age 37)
link between AMR and HAIs
Physicians employed by an MSF-supported hospital; interviewed regarding
Physicians (60% male, mean
perceived challenges to war wound management; identified lack of resources as
age 37)
barrier to protocol adherence
Patients received surgical treatment for conflict-related injuries at an MSFSyrian civilians (86% male,
supported hospital; open cohort study with longitudinal data collection was
mean age 27)
conducted; 73% of patients had MDR infections; length of stay for patients with
MDR infection was about 42 days longer than patients without infection
Patients admitted to an MSF-supported program in Jordan for treatment; lab
Iraqi, Syrian, and Yemeni
data from the MSF database was retrospectively analyzed; 77% of patients had
civilians with war-related
> 1 sample positive for FLAR; FLAR was associated with lower limb injury,
injuries
>12 months since injury, and more than 3 previous surgeries
Pakistan
Cross-sectional study to determine prevalence of MDR-TB in this region was
Residents of Khyber
conducted; recruited patients who never received treatment for TB (CAT I) and
Pakhtunkhwa province (51% patients who received treatment and failed or relapsed (CAT II); MDR-TB
male, mean age 31)
found to be more prevalent in CAT II patients who previously failed treatment
than CAT I patients
Refugees recruited from five different villages near the Peshawar Provence;
Afghan refugees (58% male) randomized to one of six treatment arms; chloroquine was deemed
with falciparum malaria
inappropriate for malaria treatment; sulfadoxine-pyrimethamine (SP) +
artesunate (AS) were deemed most effective

-

250
10
10

457

727

139

308

iii
Rafei &
Dabboussi et
al., 2013
Rafei &
Pailhories et
al., 2015

Lebanon

Syrian refugees with warrelated wounds

Syrian refugees and
Lebanon Lebanese patients (78%
male, mean age 40)

Hamze et al.,
2015

Lebanon Syrian and Lebanese patient

Araj et al.,
2016

Lebanon

Salloum et al.,
2018

Lebanon Syrian infant

El Achkar et
al., 2019

Individuals with suspected
Lebanon cases of TB (51% male,
mean age 34)

Yuce et al.,
2017
Dogru et al.,
2017

Individuals residing in
Lebanon

Turkey

Syrian patients (58% male,
mean age 27)

Turkey

Syrian patients (61% male,
mean age 32) and Turkish
patients (67% male, mean
age 45)

Lebanon
Patients treated at the Tripoli Government Hospital; patient isolates were
collected and tested for carbapenem-resistant A. baumannii; four isolates
identified with high-level resistance
Patients treated at different hospitals in Tripoli, Lebanon; isolates were collected
and tested for resistance to antibiotics; 60% of isolates exhibited carbapenem
resistance
Patient isolates collected by the National Commission for Biotechnology in
Syria and the Azm Center for Research in Biotechnology in Beirut; utility of
pyrosequencing technology for the detection of MDR-TB was evaluated;
technology was found to be 72.6% sensitive to INH resistance
Data collected by the National Tuberculosis Program (NTP) or the Clinical
Microbiology Laboratory (CML) at the American University of Beirut Medical
Center; data was retrospectively analyzed; >7500 cases of TB reported since
2011; increase in TB cases likely attributable to influx of Syrian refugees
Case report on S. pneumoniae responsible for the death of 10-month old Syrian
infant; comparative genome analysis of S. pneumonia from infant and 24 other S.
pneumoniae genomes from publicly available dataset was conducted; isolate
collected from infant exhibited potential for “pronounced invasiveness” and
resistance
Data reported to a national TB program in Lebanon; data was retrospectively
analyzed; 250 confirmed cases of TB; 3% of cases found to be resistant to RIF
Turkey
Patients treated for burns at the Dr. Lutfi Kirdar Kartal Educating and Training
Hospital Burn Centre of Istanbul; patient data retrospectively analyzed; high
prevalence of infection with resistant pathogens observed in patients with
conflict-related burns
Patients registered to the Hatay TB Outpatient Clinic; retrospective comparative
analysis of incident TB cases and treatment success between Turkish and Syrian
patients was conducted; treatment success rate amongst Syrian patients found to
be lower than Turkish patients (64% vs. 89%, p<0.001)

116

66

-

25

720

43

211
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Table 3. Recommended AMR Control Strategies
Author

Bhalla et al.,
2016

ASP

Hamze et al.,
2015

DS

Kolaczinski et
al., 2012

O

Ghafoor et al.,
2012

DS

Rafei &
Dabboussi et
al., 2013
Rafei &
Pailhories et
al., 2015
Araj et al.,
2016
Al Baz et al.,
2017
Dogru et al.,
2017
Salloum et al.,
2017
Yuce et al.
2017

Duration of
Recommendation Details
Study/Data
Intervention Outcomes and Details
Collection Period
Strategy Recommended and Evidence for Effectiveness Provided in Article
Implementation of antibiotic
When compared to the previous year,
stewardship program that adhere to
antibiotic costs following ASP
2013-2014
guidelines set by the Centers for Disease
implementation dropped from ~$252,077 to
Control (CDC)
~$159,948
Culture-based screening for MDR-TB can
Use of pyrosequencing for rapid and
take up to 4-weeks; pyrosequencing
highly-sensitive detection of MDR-TB
technology more rapidly detects resistance to
resistant to RIF and INH
INH with 72.6% sensitivity
Patients treated with chloroquine had a
Change in first-line malaria treatment
clinical failure rate of 81% at 28 days followfrom chloroquine to combination
2000-2003
up; patients treated with SP + AS had a
therapy (SP + AS)
treatment failure rate of 2.4% at follow-up
Strategy Recommended but no Evidence for Effectiveness Provided in Article**
Implementation of MDR-TB
surveillance program; monitor patients
2009
with past treatment failure
Utilization of IPC measures to prevent
transmission of carbapenem-resistant A.
2012
baumannii

Recommendation
Type(s)*

IPC
IPC
DS
E
DS
DS
IPC

Utilization of IPC measures to prevent
spread of resistant A. baumannii
Improved lab diagnostics for more rapid
and accurate MDR-TB testing
Increased education on proper antibiotic
use amongst refugee groups
Implementation of national TB
surveillance program
Use of whole genome sequencing for
TB surveillance
Accelerated transfer of burn victims to
treatment centers

2011-2013

-

-

-

-

-

2010-2013

-

-

-

2011-2015

-

v
Alga & Herzog
et al., 2018a

E, IPC

Alga & Herzog
et al., 2018b

O

Alga & Wong
et al., 2018

ASP

Fily et al., 2019

ASP, DS

El Achkar et
al., 2019

DS

Increased physician education on
antibiotics and HAIs; improved IPC
Development of war wound
management protocols/guidelines
specific to conflict-afflicted settings
Implementation of more rigorous
protocols for antibiotic use
Implementation of high-skill
laboratories; implementation of ASPs
Increased testing of TB resistance prior
to treatment decisions; improved lab
diagnostics

-

-

2015

-

2014-2016

-

2006-2016

-

2016-2017

-

* Abbreviations for control strategy categories: infection prevention and control (IPC); antibiotic stewardship program (ASP); diagnostics and surveillance (DS);
education (E); other (O).
** Interventions in this category were suggested by the study authors, but no or limited supporting evidence for the strategy’s effectiveness was provided.
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Fig. 1 Study Selection
599 records identified through
database searching
-

PubMed: n=220
Embase: n=158
Scopus: n= 221

152 duplicate records removed

447 records identified for title and
abstract screening
399 records excluded
-

Published before Jan. 2010: n=156
Not topically relevant: n=237
Full-text not in English: n=6

48 records identified for full-text
screening
32 records excluded
16 studies included in review

Not primary research: n=23
No discussion of control: n=9

